Scarica l'app Stockscreener
1.29
5.31%
0.065
Heartbeam Inc Borsa (BEAT) Ultime notizie
HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology - TipRanks
IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch - Yahoo Finance
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 - Business Wire
BEAT Stock: A Comprehensive Analysis and Forecast - investchronicle.com
HeartBeam Inc. Pioneers Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring - citybuzz -
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG - citybuzz -
HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG - financial-news.co.uk
HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results - citybuzz -
Here's Why HeartBeam (NASDAQ:BEAT) Must Use Its Cash Wisely - Yahoo Finance
HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing
Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India
HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com
HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus
HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer
HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa
Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView
HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria
HeartBeam, Inc. SEC 10-Q Report - TradingView
HeartBeam Reports First Quarter 2025 Results - Business Wire
The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail
HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance
Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com
Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT) - Barchart.com
HeartBeam Secures 2 New U.S. Patents - Medical Product Outsourcing
HeartBeam (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio - Barchart.com
HeartBeam (BEAT) Expands IP Portfolio with New U.S. Patents | BEAT Stock News - GuruFocus
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire
HeartBeam Expands Board with CEO Robert Eno’s Appointment - citybuzz -
HeartBeam (NASDAQ: BEAT) Appoints CEO Robert Eno To Board Of Directors - Barchart.com
HeartBeam (BEAT) Welcomes CEO Robert Eno to Its Board of Directo - GuruFocus
HeartBeam Appoints CEO Robert Eno to Board - TipRanks
HeartBeam expands board, appoints CEO to director role By Investing.com - Investing.com India
HeartBeam expands board, appoints CEO to director role - Investing.com Australia
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Bluefield Daily Telegraph
HeartBeam, Inc. Appoints Robert Eno to Board of Directors - marketscreener.com
HeartBeam CEO Robert Eno joins company’s board as commercialization nears - Medical Economics
HeartBeam (NASDAQ: BEAT) Prices $10 Million Public Offering At $1.70 Per Share - Barchart.com
HeartBeam (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13 - Barchart.com
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Bluefield Daily Telegraph
HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis - Yahoo Finance
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - BioSpace
Strategic Collaboration with AccurKardia for Ambulatory ECG - openPR.com
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) - The Globe and Mail
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) | FinancialContent - FinancialContent
1.70%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):